496 related articles for article (PubMed ID: 31897672)
1. Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature.
Banys-Paluchowski M; Gruber IV; Hartkopf A; Paluchowski P; Krawczyk N; Marx M; Brucker S; Hahn M
Arch Gynecol Obstet; 2020 Feb; 301(2):341-353. PubMed ID: 31897672
[TBL] [Abstract][Full Text] [Related]
2. Feasibility of targeted axillary dissection for de-escalation of surgical treatment after neoadjuvant chemotherapy in breast cancer.
Aragón-Sánchez S; Ciruelos-Gil E; López-Marín L; Galindo A; Tabuenca-Mateos MJ; Jiménez-Arranz S; Colmenero-Hernández M; Oliver-Pérez MR
Surg Oncol; 2022 Sep; 44():101823. PubMed ID: 36041377
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative Ultrasound-Guided Excision of Axillary Clip in Patients with Node-Positive Breast Cancer Treated with Neoadjuvant Therapy (ILINA Trial) : A New Tool to Guide the Excision of the Clipped Node After Neoadjuvant Treatment.
Siso C; de Torres J; Esgueva-Colmenarejo A; Espinosa-Bravo M; Rus N; Cordoba O; Rodriguez R; Peg V; Rubio IT
Ann Surg Oncol; 2018 Mar; 25(3):784-791. PubMed ID: 29197044
[TBL] [Abstract][Full Text] [Related]
4. The problem of axillary staging in breast cancer after neoadjuvant chemotherapy. Role of targeted axillary dissection and types of lymph node markers.
Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Aguayo-Albasini JL
Cir Esp (Engl Ed); 2020 Nov; 98(9):510-515. PubMed ID: 32386728
[TBL] [Abstract][Full Text] [Related]
5. Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.
Caudle AS; Yang WT; Krishnamurthy S; Mittendorf EA; Black DM; Gilcrease MZ; Bedrosian I; Hobbs BP; DeSnyder SM; Hwang RF; Adrada BE; Shaitelman SF; Chavez-MacGregor M; Smith BD; Candelaria RP; Babiera GV; Dogan BE; Santiago L; Hunt KK; Kuerer HM
J Clin Oncol; 2016 Apr; 34(10):1072-8. PubMed ID: 26811528
[TBL] [Abstract][Full Text] [Related]
6. Validation of the targeted axillary dissection technique in the axillary staging of breast cancer after neoadjuvant therapy: Preliminary results.
Flores-Funes D; Aguilar-Jiménez J; Martínez-Gálvez M; Ibáñez-Ibáñez MJ; Carrasco-González L; Gil-Izquierdo JI; Chaves-Benito MA; Ayala-De La Peña F; Nieto-Olivares A; Aguayo-Albasini JL
Surg Oncol; 2019 Sep; 30():52-57. PubMed ID: 31500785
[TBL] [Abstract][Full Text] [Related]
7. Initial results of a novel technique of clipped node localization in breast cancer patients postneoadjuvant chemotherapy: Skin Mark clipped Axillary nodes Removal Technique (SMART trial).
Lim GH; Teo SY; Gudi M; Ng RP; Pang J; Tan YS; Lee YS; Allen JC; Leong LCH
Cancer Med; 2020 Mar; 9(6):1978-1985. PubMed ID: 31970894
[TBL] [Abstract][Full Text] [Related]
8. Initial experience with targeted axillary dissection after neoadjuvant therapy in breast cancer patients.
Pinto CS; Peleteiro B; Pinto CA; Osório F; Costa S; Magalhães A; Mora H; Amaral J; Gonçalves D; Fougo JL
Breast Cancer; 2022 Jul; 29(4):709-719. PubMed ID: 35304711
[TBL] [Abstract][Full Text] [Related]
9. Would Removal of All Ultrasound Abnormal Metastatic Lymph Nodes Without Sentinel Lymph Node Biopsy Be Accurate in Patients with Breast Cancer with Neoadjuvant Chemotherapy?
Lim GH; Gudi M; Teo SY; Ng RP; Yan Z; Lee YS; Allen JC; Leong LCH
Oncologist; 2020 Nov; 25(11):e1621-e1627. PubMed ID: 32537791
[TBL] [Abstract][Full Text] [Related]
10. Feasibility and safety of targeted axillary dissection guided by intraoperative ultrasound after neoadjuvant treatment.
Siso C; Esgueva A; Rivero J; Morales C; Miranda I; Peg V; Gil-Moreno A; Espinosa-Bravo M; Rubio IT
Eur J Surg Oncol; 2023 Oct; 49(10):106938. PubMed ID: 37244843
[TBL] [Abstract][Full Text] [Related]
11. Carbon nanoparticles localized clipped node dissection combined with sentinel lymph node biopsy with indocyanine green and methylene blue after neoadjuvant therapy in node positive breast cancer in China: initial results of a prospective study.
Yang X; Li Y; Ren XT; Fan L; Hua B
World J Surg Oncol; 2023 Jul; 21(1):214. PubMed ID: 37480099
[TBL] [Abstract][Full Text] [Related]
12. Axillary ultrasonography combined with pre-operative wire localisation of clipped node in nodal restaging after neoadjuvant chemotherapy in node positive breast cancer patients: a pilot study.
Pulappadi VP; Paul S; Hari S; Dhamija E; Manchanda S; Kataria K; Mathur S; Mani K; Gogia A; Deo S
Br J Radiol; 2021 Nov; 94(1127):20210788. PubMed ID: 34491822
[TBL] [Abstract][Full Text] [Related]
13. Targeted axillary dissection using Radioguided Occult Lesion Localization technique in the clinically negative marked lymph node after neoadjuvant treatment in breast cancer patients.
Del Castillo A; Gomez-Modet S; Mata JM; Tejedor L
Eur J Surg Oncol; 2023 Jul; 49(7):1184-1188. PubMed ID: 36958951
[TBL] [Abstract][Full Text] [Related]
14. Node-Positive Patients Treated with Neoadjuvant Chemotherapy Can Be Spared Axillary Lymph Node Dissection with Wireless Non-Radioactive Localizers.
Laws A; Dillon K; Kelly BN; Kantor O; Hughes KS; Gadd MA; Smith BL; Lamb LR; Specht M
Ann Surg Oncol; 2020 Nov; 27(12):4819-4827. PubMed ID: 32740737
[TBL] [Abstract][Full Text] [Related]
15. Targeted axillary dissection with preoperative tattooing of biopsied positive axillary lymph nodes in breast cancer.
Gatek J; Petru V; Kosac P; Ratajsky M; Duben J; Dudesek B; Jancik P; Zabojnikova M; Katrusak J; Opelova P; Podrazska L; Vazan P; Kudlova P; Holik P; Melichar B; Vrana D
Neoplasma; 2020 Nov; 67(6):1329-1334. PubMed ID: 32749847
[TBL] [Abstract][Full Text] [Related]
16. Ultrasound guided tattooing of axillary lymph nodes in breast cancer patients prior to neoadjuvant therapy, and identification of tattooed nodes at the time of surgery.
Allweis TM; Menes T; Rotbart N; Rapson Y; Cernik H; Bokov I; Diment J; Magen A; Golan O; Levi-Bendet N; Givon Madhala O; Grubstein A
Eur J Surg Oncol; 2020 Jun; 46(6):1041-1045. PubMed ID: 31801656
[TBL] [Abstract][Full Text] [Related]
17. Axillary ultrasound after neoadjuvant therapy reduces the false-negative rate of sentinel lymph node biopsy in patients with cytologically node-positive breast cancer.
Liu Y; Wang Y; Feng S; Xu Z; Yao M; Huang X; Li P; Wu L; Liu C; Chen X; Liang C; Liu Z
Breast Cancer Res Treat; 2023 Feb; 197(3):515-523. PubMed ID: 36513955
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of Preoperative Axillary Lymph Node Marking with a Clip in Breast Cancer Patients Before Neoadjuvant Chemotherapy: A Preliminary Study.
Kim EY; Byon WS; Lee KH; Yun JS; Park YL; Park CH; Youn IY; Choi SH; Choi YJ; Kook SH; Do SI
World J Surg; 2018 Feb; 42(2):582-589. PubMed ID: 28808843
[TBL] [Abstract][Full Text] [Related]
19. SPECT/CT Lymphoscintigraphy Guidance Simplifies and Improves Targeted Axillary Dissection of the Clipped Nodes After Neoadjuvant Chemotherapy in Initially Node-Positive Breast Cancer.
Has Simsek D; Emiroglu S; Yilmaz R; Bayram A; Isik EG; Tukenmez M; Kuyumcu S; Dursun M; Muslumanoglu M; Cabioglu N
Clin Nucl Med; 2022 Nov; 47(11):e682-e688. PubMed ID: 35835147
[TBL] [Abstract][Full Text] [Related]
20. Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial.
Caudle AS; Yang WT; Mittendorf EA; Black DM; Hwang R; Hobbs B; Hunt KK; Krishnamurthy S; Kuerer HM
JAMA Surg; 2015 Feb; 150(2):137-43. PubMed ID: 25517573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
